Active — Not RecruitingNot Applicable

Muscle Dysfunction in Patients With Haematological Diseases

Denmark216 participantsStarted 2023-10-01

Plain-language summary

PURPOSE: To evaluate the prevalence and prognostic value of sarcopenia in patients diagnosed with hematological cancer diseases.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: • Patients diagnosed with malignant lymphomas, acute leukaemia and multiple myeloma referred to treatment at the Department of Haematology, Rigshospitalet. Exclusion Criteria: * Age: \<18 * Pregnancy * Physical or mental disabilities precluding test of muscle function * Inability to read and understand Danish.

What they're measuring

Change in Whole body Lean body Mass

Timeframe: Baseline and 6 months after treatment start

Trial details

NCT IDNCT05150561

SponsorRigshospitalet, Denmark

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-10-30

View on ClinicalTrials.gov More Hematologic Diseases trials